Key statistics
On Friday, Guardant Health Inc (GH:NSQ) closed at 28.61, -22.76% below its 52-week high of 37.04, set on Jul 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 28.58 |
---|---|
High | 29.78 |
Low | 28.20 |
Bid | 26.01 |
Offer | 29.67 |
Previous close | 28.59 |
Average volume | 2.51m |
---|---|
Shares outstanding | 123.55m |
Free float | 117.92m |
P/E (TTM) | -- |
Market cap | 3.53bn USD |
EPS (TTM) | -4.24 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
- Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
- Guardant Health to Participate in Upcoming Investor Conferences
- Guardant Health Named to TIME’s List of the Best Inventions of 2024
- Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024
- Roberto A. Mignone Joins Guardant Health Board of Directors
- Guardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024
- GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long
- Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types
- Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy
- Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
More ▼